BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17920082)

  • 1. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit.
    Salas R; Main A; Gangitano D; De Biasi M
    Neuropharmacology; 2007 Dec; 53(7):863-9. PubMed ID: 17920082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
    Jackson A; Papke RL; Damaj MI
    Psychopharmacology (Berl); 2018 Jul; 235(7):1897-1905. PubMed ID: 29549391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.
    Stoker AK; Olivier B; Markou A
    Behav Genet; 2012 May; 42(3):423-36. PubMed ID: 22009521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit.
    Salas R; Pieri F; De Biasi M
    J Neurosci; 2004 Nov; 24(45):10035-9. PubMed ID: 15537871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.
    Jackson KJ; Martin BR; Changeux JP; Damaj MI
    J Pharmacol Exp Ther; 2008 Apr; 325(1):302-12. PubMed ID: 18184829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinic acetylcholine receptor antagonists alter the function and expression of serine racemase in PC-12 and 1321N1 cells.
    Singh NS; Paul RK; Ramamoorthy A; Torjman MC; Moaddel R; Bernier M; Wainer IW
    Cell Signal; 2013 Dec; 25(12):2634-45. PubMed ID: 24012499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α7 Nicotinic acetylcholine receptors in the central amygdaloid nucleus alter naloxone-induced withdrawal following a single exposure to morphine.
    Ishida S; Kawasaki Y; Araki H; Asanuma M; Matsunaga H; Sendo T; Kawasaki H; Gomita Y; Kitamura Y
    Psychopharmacology (Berl); 2011 Apr; 214(4):923-31. PubMed ID: 21125398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of both alpha7* and beta2* nicotinic acetylcholine receptors is necessary to prevent development of sensitization to cocaine-elicited increases in extracellular dopamine levels in the ventral striatum.
    Zanetti L; de Kerchove D'Exaerde A; Zanardi A; Changeux JP; Picciotto MR; Zoli M
    Psychopharmacology (Berl); 2006 Aug; 187(2):181-8. PubMed ID: 16826402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Null mutation of the β2 nicotinic acetylcholine receptor subunit attenuates nicotine withdrawal-induced anhedonia in mice.
    Stoker AK; Marks MJ; Markou A
    Eur J Pharmacol; 2015 Apr; 753():146-50. PubMed ID: 25107281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of [3H]methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain.
    Mugnaini M; Tessari M; Tarter G; Merlo Pich E; Chiamulera C; Bunnemann B
    Eur J Neurosci; 2002 Nov; 16(9):1633-46. PubMed ID: 12431215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nicotinic mechanism underlies β-amyloid-induced neurotoxicity.
    Liu Q; Xie X; Emadi S; Sierks MR; Wu J
    Neuropharmacology; 2015 Oct; 97():457-63. PubMed ID: 25959067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice--a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors.
    Raybuck JD; Gould TJ
    Eur J Neurosci; 2009 Jan; 29(2):377-87. PubMed ID: 19200240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors.
    Tucci SA; Genn RF; File SE
    Neuropharmacology; 2003 Mar; 44(3):367-73. PubMed ID: 12604094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice.
    Salas R; Sturm R; Boulter J; De Biasi M
    J Neurosci; 2009 Mar; 29(10):3014-8. PubMed ID: 19279237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice.
    Walters CL; Brown S; Changeux JP; Martin B; Damaj MI
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):339-44. PubMed ID: 16416156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of aggressive behavior in mice by nicotinic receptor subtypes.
    Lewis AS; Mineur YS; Smith PH; Cahuzac ELM; Picciotto MR
    Biochem Pharmacol; 2015 Oct; 97(4):488-497. PubMed ID: 26212554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in cholinergic systems in the interpeduncular nucleus following nicotine exposure and withdrawal.
    Correa VL; Flores RJ; Carcoba LM; Arreguin MC; O'Dell LE
    Neuropharmacology; 2019 Nov; 158():107714. PubMed ID: 31325431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning.
    Kenney JW; Raybuck JD; Gould TJ
    Hippocampus; 2012 Aug; 22(8):1681-90. PubMed ID: 22271264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration.
    Pons S; Fattore L; Cossu G; Tolu S; Porcu E; McIntosh JM; Changeux JP; Maskos U; Fratta W
    J Neurosci; 2008 Nov; 28(47):12318-27. PubMed ID: 19020025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.
    Jackson A; Bagdas D; Muldoon PP; Lichtman AH; Carroll FI; Greenwald M; Miles MF; Damaj MI
    Neuropharmacology; 2017 May; 118():38-45. PubMed ID: 28279662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.